Emily J Anstadt

Years Active: 2022-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Emily J Anstadt, Ruben Carmona, Eva Berlin, Nikhil Yegya-Raman, Sriram Venigalla, Vishruth Reddy, Graeme R Williams, Mark R Leibensperger, Andrzej Wojcieszynski, Brian C Baumann, Major K Lee, John P Plastaras, Emma E Furth, Loren K Mell, James M Metz, Edgar Ben-Josef
SMAD4 loss predicts worse overall and distant metastasis-free survival in patients with resected pancreatic adenocarcinoma. Cancer (2023)
Emily J Anstadt, Brian Chu, Nikhil Yegya-Raman, Xiaoyan Han, Abigail Doucette, Kendra Poirier, Jahan J Mohiuddin, Amit Maity, Andrea Facciabene, Ravi K Amaravadi, Giorgos C Karakousis, Justine V Cohen, Tara C Mitchell, Lynn M Schuchter, John N Lukens
Moderate Colitis Not Requiring Intravenous Steroids Is Associated with Improved Survival in Stage IV Melanoma after Anti-CTLA4 Monotherapy, But Not Combination Therapy. The oncologist 27 (9) (2022)